Feed AMRX
AM

Amneal Pharmaceuticals AMRX · NASDAQ

$19.36 +0.94% (+$0.18)

Market cap
$6.18B
Enterprise value
$8.85B
P/E
39.3x
Forward P/E
18.5x
PEG
-
P/S
2.0x
P/FCF
74.4x
EV/EBITDA
13.6x
ROIC
14.3%
Bruto marža
39.3%
Neto marža
5.0%
Dividend yield
-
Payout ratio
-
Neto dolg/EBITDA
4.1x
Beta
1.22
Free float
45.0%

O podjetju

Amneal Pharmaceuticals, Inc. is an American pharmaceutical company focused on the development, manufacturing, and distribution of generic and specialty medications. The company specializes in a broad range of therapeutic areas, including cardiovascular diseases, neurological disorders, oncology, and more. Amneal also produces its own branded products targeting specific conditions. The company is known for its ability to provide affordable medications while continuing to develop innovative therapies.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Chirag K. Patel

Employees

8,700

Headquarters

Bridgewater

Vrednotenje

Je današnja cena primerna?

Rast in ocene

Ali podjetje raste in kaj sledi?

Donosnost in kakovost

Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?

Finančno zdravje

Ali zmore svoj dolg?

Kapital in dividende

Kaj podjetje počne z zasluženim denarjem?

Analitiki

Kaj menijo strokovnjaki in ali se to spreminja?

Lastniki in insajderji

Kdo ima delnice in kaj počne vodstvo?

Segmenti

Kateri del podjetja raste?

Primerjava s konkurenco

Kako se primerja s podobnimi podjetji?

Cena in tveganje

Kako se delnica obnaša?

Izkazi

Vse številke

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.